PharmExec Direct: Having trouble viewing the email? Click Here

IN THIS ISSUE

Pharm Exec's Emerging Pharma Leaders

UBM to Launch BioLive Event in 2018

Developing Drugs for
Rare Diseases

Top Story
Pharm Exec's 2018 Pipeline Report
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods—and the realization that failures have their place in shaping the pipeline of tomorrow. Josh Baxt reports
... /Read more/
Advertisement
Launching into Value: Pharma's Quest to Align Drug Prices with Outcomes
On Demand
Learn more
Asia
Taiwan's Biotech Boom
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups. Michelle Maskaly reports
... /Read more/
Europe
Pharma & Patient Group Collaboration: A Fine Line
Can health stakeholders be friends without being captives? Reflector reports
... /Read more/
UK
Government (Finally) Responds to Accelerated Access Review
A year after the Accelerated Access Review explored how to speed up adoption of innovation across the NHS in England, the UK Government has responded. Leela Barham reports
... /Read more/
Profile
Resilience in a Sea of Change: Ed Gudaitis, GM – Canada, Allergan
Ed Gudaitis Allergan VP and Country Manager, Canada, explains how embracing disruption is his secret to success
... /Read more/
Calendar
/ 14 November: EU GDPR Bootcamp Life Sciences /
London, UK
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Commercial Data Insights /
Philadelphia, PA
/ December 4–5: Connected Devices in Healthcare /
San Diego, CA
/ December 12: Specialty Products Data Strategy Summit /
Philadelphia, PA
/ January 23–24: 13th Biosimilars Summit /
Alexandria, VA
/ January 24–25: Reimbursement and Contracting /
Philadelphia, PA
/ February 7–8, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
Industry update
//ALK (Copenhagen, Denmark) announced the appointment of Søren Jelert as its new Chief Financial Officer and Executive Vice President. //The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA; Geneva, Switzerland) named Helen Gallagher as Communications Director. //DelMar Pharmaceuticals (Vancouver, British Columbia and Menlo Park, CA) announced the appointment of Mr. Saiid Zarrabian as interim Chief Executive Officer. //Cambridge Epigenetix (Saffron Walden, UK) appointed Hayden Jeffreys as Chief Operating Officer and Dr. Joanne Mason as Vice President of Biomarker Discovery. //
update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com